Detection of mycobacterial DNA from sputum of patients with cystic fibrosis
Background Patients with cystic fibrosis (CF) are at high risk from atypical mycobacterial infections. There have been few attempts to delineate the intensity of mycobacterial infection in CF patients in Ireland.
Aims To examine the incidence of mycobacterial DNA in an archived collection of genomic DNA extracted from the sputa of CF patients within the Northern Ireland population.
Methods One hundred and eighty-two CF patients (66 adults and 116 children) were examined for the presence of mycobacterial DNA in their sputum by a genus specific PCR assay based on 16S rRNA, followed by direct automated sequencing of the PCR amplicons.
Results One of 116 (0.9%) children and 2 of 66 adults were positive. Sequence identity revealedMycobacterium xenopi in the paediatric patient andM. xenopi andM. chelonei in the two adult patients. False-positive results occurred in 11 patients (four adults), mainly due toCorynebacterium spp.
Conclusions There was a low prevalence ofMycobacterium spp in the CF patient population. All PCR positive results should be confirmed by direct automated sequencing and an alternative specific assay employed. Enhanced molecular screening will contribute in understanding their role as opportunistic pathogens in patients with worsening lung function.
KeywordsCystic Fibrosis Cystic Fibrosis Patient Nontuberculous Mycobacterium Cystic Fibrosis Sputum Belfast City Hospital
Hutchison ML, Govan JR. Pathogenicity of microbes associated with cystic fibrosis.Microbes Infect
1999; 1: 1005–14.PubMedCrossRefGoogle Scholar
Cullen AR, Cannon CL, Mark EJ et al. Mycobacterium abscessus infection in cystic fibrosis. Colonisation or infection?Am J Respir Crit Care Med
2000; 161: 641–45.PubMedGoogle Scholar
Kulski JK, Khinsoe C, Pryce T et al. Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patients.J Clin Microbiol
1995; 33: 668–74.PubMedGoogle Scholar
Millar B, Moore J, Mallon P et al. Molecular diagnosis of infective endocarditis - a new Duke’s criterion.Scand J Infect Dis
2001; 33 (9): 673- 80.PubMedCrossRefGoogle Scholar
Goldenberger D, Kunzli A, Vogt P et al. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing.J Clin Microbiol
1997; 35: 2733–9.PubMedGoogle Scholar
Griffith DE. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis.Am J Respir Crit Care Med
2003; 167: 810–2.PubMedCrossRefGoogle Scholar
Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis.Clin Chest Med
2002; 23: 655–63.PubMedCrossRefGoogle Scholar
Olivier KN, Weber DJ, Wallace RJ Jr et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.Am J Respir Crit Care Med
2003; 167: 828–34.PubMedCrossRefGoogle Scholar
Olivier KN, Weber DJ, Lee JH et al. Nontuberculous mycobacteria. II: nested- cohort study of impact on cystic fibrosis lung disease.Am J Respir Crit Care Med
2003; 167: 835–840.PubMedCrossRefGoogle Scholar
Oliver A, Maiz L, Canton R et al. Nontuberculous mycobacteria in patients with cystic fibrosis.Clin Infect Dis
2001; 32: 1298–303.PubMedCrossRefGoogle Scholar
Bange FC, Brown BA, Smaczny C et al. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.Clin Infect Dis
2001; 32: 1648–50.PubMedCrossRefGoogle Scholar
Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis.Am J Respir Crit Care Med
2003; 168: 918–51.PubMedCrossRefGoogle Scholar